- Advertisement -

New SMArT platform improves safety of CRISPR gene editing

A team of researchers led by Luigi Naldini at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) has developed a new strategy to...

What Is Biotechnology? Where Is It Headed at UVA? – UVA Today

What Is Biotechnology? Price said context helps when discussing what biotechnology means. “To me, the term ‘biotechnology’ has conventionally meant the process of...

Graduate Aptitude Test in Biotechnology: Apply by June 18 – Mathrubhumi English

Applications have been invited for the Graduate Aptitude Test - Biotechnology (GAT-B), an examination to rank the participants for admission to the various DBT-supported...

Nautilus Biotechnology Launches “First Access Challenge” – GlobeNewswire

SEATTLE, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying...

From Good to Great: Bonum Therapeutics Raises $93M Series A with...

John Mulligan, PhD, founder and CEO at Bonum Therapeutics. Bonum Therapeutics, a biopharmaceutical startup that uses allosteric control to develop conditionally active and less toxic...

RUDN University biologists discover the way how macrophages respond to inflammation

RUDN University biologists discovered the way how macrophages (the cells of the "first line" immune response) respond to inflammation and identified how the immune...

Recoded E. coli Promises More Scalable Weight Loss Drug Production

The manufacturing of weight loss drugs at large scale could get cheaper and more sustainable thanks to an engineered strain of Escherichia coli (E....

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell...

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

Recoded E. coli Promises More Scalable Weight Loss Drug Production

The manufacturing of weight loss drugs at large scale could get cheaper and more sustainable thanks to an engineered strain of Escherichia coli (E....

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell Engineering

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell Engineering

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

more new items

Recoded E. coli Promises More Scalable Weight Loss Drug Production

The manufacturing of weight loss drugs at large scale could get cheaper and more sustainable thanks to an engineered strain of Escherichia coli (E....

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell...

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell...

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...